NEXN

nexilin F-actin binding protein, the group of I-set domain containing

Basic information

Region (hg38): 1:77888513-77943895

Links

ENSG00000162614NCBI:91624OMIM:613121HGNC:29557Uniprot:Q0ZGT2AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • hypertrophic cardiomyopathy 20 (Limited), mode of inheritance: AD
  • familial isolated dilated cardiomyopathy (Supportive), mode of inheritance: AD
  • dilated cardiomyopathy 1CC (Limited), mode of inheritance: AD
  • hypertrophic cardiomyopathy 20 (Limited), mode of inheritance: AD
  • hypertrophic cardiomyopathy (Limited), mode of inheritance: AD
  • dilated cardiomyopathy (Moderate), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Cardiomyopathy, familial hypertrophic, 20; Cardiomyopathy, dilated, 1CCADCardiovascularSurveillance (eg, including echocardiogram/electocardiogram) and preventive measures, including medical management, may reduce morbidity and severe sequelae such as sudden cardiac death; Cardiac transplantation has ben reportedCardiovascular19881492; 20970104

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the NEXN gene.

  • Dilated cardiomyopathy 1CC;Hypertrophic cardiomyopathy 20 (8 variants)
  • Hypertrophic cardiomyopathy 20;Dilated cardiomyopathy 1CC (5 variants)
  • Dilated cardiomyopathy 1CC (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the NEXN gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
2
clinvar
123
clinvar
1
clinvar
126
missense
1
clinvar
327
clinvar
7
clinvar
3
clinvar
338
nonsense
4
clinvar
12
clinvar
16
start loss
1
clinvar
1
frameshift
9
clinvar
29
clinvar
38
inframe indel
17
clinvar
17
splice donor/acceptor (+/-2bp)
4
clinvar
5
clinvar
9
splice region
12
9
21
non coding
4
clinvar
49
clinvar
21
clinvar
74
Total 13 5 397 179 25

Highest pathogenic variant AF is 0.00000658

Variants in NEXN

This is a list of pathogenic ClinVar variants found in the NEXN region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
1-77888598-A-ACGG Dilated Cardiomyopathy, Dominant • Hypertrophic cardiomyopathy Uncertain significance (Jun 14, 2016)298084
1-77888754-T-C not specified Benign (Feb 24, 2014)138513
1-77888795-T-G Likely benign (Jan 07, 2021)1194335
1-77888900-G-T Benign (Jun 23, 2018)1233836
1-77916039-T-C not specified Benign (Sep 17, 2014)201911
1-77916044-AT-A Likely benign (Feb 13, 2024)518082
1-77916064-T-A not specified Likely benign (Nov 02, 2017)513029
1-77916073-C-A not specified Benign (Jun 23, 2014)201912
1-77916097-T-C not specified Uncertain significance (Jul 24, 2014)179916
1-77916106-C-T Cardiovascular phenotype Uncertain significance (Jul 30, 2020)1784192
1-77916107-A-C Cardiovascular phenotype • Dilated cardiomyopathy 1CC;Hypertrophic cardiomyopathy 20 Uncertain significance (Jun 09, 2023)519128
1-77916110-AATG-A Cardiovascular phenotype • Dilated cardiomyopathy 1CC;Hypertrophic cardiomyopathy 20 Uncertain significance (Oct 25, 2023)518850
1-77916114-A-T Cardiovascular phenotype • NEXN-related disorder Uncertain significance (Mar 21, 2022)1765416
1-77916121-C-T Dilated cardiomyopathy 1CC;Hypertrophic cardiomyopathy 20 Likely benign (Dec 07, 2023)2931787
1-77916129-CTGAGG-C Cardiovascular phenotype Uncertain significance (Jun 09, 2023)2561771
1-77916133-G-A Cardiovascular phenotype Uncertain significance (Aug 10, 2022)1796186
1-77916140-C-T Hypertrophic cardiomyopathy 20;Dilated cardiomyopathy 1CC Likely benign (May 03, 2021)1648949
1-77916333-T-C Benign (Jun 19, 2018)675412
1-77916353-A-C Benign (Jun 14, 2018)674339
1-77917475-AT-A Benign (Sep 27, 2018)1287762
1-77917554-C-A Hypertrophic cardiomyopathy 20;Dilated cardiomyopathy 1CC Likely benign (Mar 31, 2023)2040650
1-77917557-C-T Likely benign (Nov 26, 2019)1205626
1-77917567-T-G Cardiovascular phenotype Uncertain significance (May 11, 2023)2564020
1-77917570-T-C Cardiovascular phenotype Uncertain significance (Feb 11, 2022)1729964
1-77917581-T-C Cardiomyopathy Uncertain significance (Mar 16, 2023)2691225

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
NEXNprotein_codingprotein_codingENST00000334785 1255383
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
3.91e-110.9961247071831247910.000337
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.2083543431.030.00001754480
Missense in Polyphen115104.971.09551304
Synonymous0.1671091110.9800.000005541132
Loss of Function2.722443.30.5540.00000257521

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0004410.000439
Ashkenazi Jewish0.00009940.0000993
East Asian0.0003900.000389
Finnish0.0001390.000139
European (Non-Finnish)0.0004630.000459
Middle Eastern0.0003900.000389
South Asian0.0003600.000327
Other0.0003310.000330

dbNSFP

Source: dbNSFP

Function
FUNCTION: Involved in regulating cell migration through association with the actin cytoskeleton. Has an essential role in the maintenance of Z line and sarcomere integrity. {ECO:0000269|PubMed:12053183, ECO:0000269|PubMed:15823560, ECO:0000269|PubMed:19881492}.;
Disease
DISEASE: Cardiomyopathy, familial hypertrophic 20 (CMH20) [MIM:613876]: A hereditary heart disorder characterized by ventricular hypertrophy, which is usually asymmetric and often involves the interventricular septum. The symptoms include dyspnea, syncope, collapse, palpitations, and chest pain. They can be readily provoked by exercise. The disorder has inter- and intrafamilial variability ranging from benign to malignant forms with high risk of cardiac failure and sudden cardiac death. {ECO:0000269|PubMed:20970104}. Note=The disease is caused by mutations affecting the gene represented in this entry.;

Recessive Scores

pRec
0.103

Intolerance Scores

loftool
0.929
rvis_EVS
-0.05
rvis_percentile_EVS
50.34

Haploinsufficiency Scores

pHI
0.192
hipred
N
hipred_score
0.448
ghis
0.539

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.0145

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Nexn
Phenotype
mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); muscle phenotype;

Zebrafish Information Network

Gene name
nexn
Affected structure
atrium
Phenotype tag
abnormal
Phenotype quality
increased width

Gene ontology

Biological process
homophilic cell adhesion via plasma membrane adhesion molecules;axon guidance;response to bacterium;regulation of cell migration;regulation of cytoskeleton organization;dendrite self-avoidance
Cellular component
cytoskeleton;plasma membrane;focal adhesion;Z disc;axon
Molecular function
structural constituent of muscle;actin filament binding;cell-cell adhesion mediator activity